Relationship of timing of agonist administration in the cycle phase to the ovarian response to gonadotropins in the long down-regulation protocols for assisted reproductive technologies

Fertility and Sterility

Volumn 65, Issue 1, 1996, Pages 114-121

  Ferraretti, A P ^a   Magli, C ^a   Feliciani, E ^a   Montanaro, N ^a   Gianaroli, L ^a  

^a SISMR   (Italy)

Author keywords

Agonist timing; assisted reproductive technologies; ovarian stimulation; program organization

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; PROGESTERONE; TRIPTORELIN; UROFOLLITROPIN;

ADULT; ARTICLE; BIRTH RATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; ECHOGRAPHY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; NIDATION; OVARY; OVARY CYST; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030058689     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(16)58037-6     Document Type: Article

References (22)

1. R. Fleming J.R.T. Coutts Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropins suppression Fertil Steril 45 1986 226 230
2. D. De Ziegler M.I. Cedars D. Randle J.K.H. Lu H.L. Judd D.R. Meldrum Suppression of the ovary using a gonadotropin releasing hormone agonist prior to stimulation for oocyte retrieval Fertil Steril 48 1987 807 810
3. L. Gianaroli A.P. Ferraretti C. Magli D. Fortini Human embryo cryopreservation F.A. Moeloek B. Affandi A.O. Trounson Advances in human reproduction 1993 The Parthenon Publishing Group London 73 83
4. G.B. Maroulis M. Emery B.S. Verkauf A. Saphier M. Bernhisel T.R. Yeko Prospective randomized study of human menotropin versus a follicular and a luteal phase gonadotropin-releasing hormone analog-human menotropin stimulation protocols for in vitro fertilization Fertil Steril 55 1991 1157 1164
5. C. Kingsland S.-L. Tan N. Bickerton B. Mason S. Campbell The routine use of gonadotropin releasing hormone agonists for all patients undergoing in vitro fertilization. Is there any medical advantage? A prospective randomized study Fertil Steril 57 1992 804 809
6. J. Dor I. Ben-Shlomo D. Levran E. Rudak M. Yunish S. Mashiach The relative success of gonadotropin-releasing hormone analogue, clomiphene citrate, and gonadotropin in 1,099 cycles of in vitro fertilization Fertil Steril 58 1992 986 990
7. D.G. Whittingham Culture of mouse ova J Reprod Fertil 14 1971 7 21
8. L. Gianaroli R. Seracchioli A.P. Ferraretti A. Trounson C. Flamigni L. Bovicelli The successful use of human amniotic fluid for mouse embryo culture and human in vitro fertilization, embryo culture, and transfer Fertil Steril 46 1986 907 913
9. L. Gianaroli A.P. Ferraretti E. Feliciani C. Tabanelli M.C. Magli D. Fortini Prospective randomized study of D-Trp6-LHRH versus buserelin in long desensitization protocols for medically assisted conception cycles Hum Reprod 9 1994 220 225
10. A.P. Ferraretti L. Gianaroli L. Diotellevi C. Festi A. Trounson Dopamine treatment for severe ovarian hyperstimulation syndrome Hum Reprod 7 1992 180 183
11. E. Loumaye The control of endogenous secretion of LH by gonadotropin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryos transfer Hum Reprod 5 1990 357 376
12. G. Oelsner D.M. Serr S. Mashiach J. Blankstein M. Snyder B. Lunenfeld The study of induction of ovulation with menotropins: analysis of results of 1897 treatment cycles Fertil Steril 30 1978 538 544
13. E. Loumaye L. Vankrieken S. Depreester I. Psalti S. de Cooman K. Thomas Hormonal changes induced by short-term administration of a gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development Fertil Steril 51 1989 105 111
14. F.S. Marcus P.R. Brinsden M. Macnamee P.A. Rainsbury K.T. Elder R.G. Edwards Comparative trial between an ultra-short and long protocol of luteinizing hormone-releasing hormone agonist for ovarian stimulation in in-vitro fertilization Hum Reprod 8 1993 238 243
15. M. Sampaio V. Serra F. Miro C. Calatayud R.M. Castellvi A. Pellicer Development of ovarian cysts during gonadotropin-releasing hormone agonists (GnRHa) administration Hum Reprod 6 1991 194 197
16. A. Herman R. Ron El A. Golan H. Nahum Y. Soffer E. Caspi Follicle cysts after menstrual versus midluteal administration of gonadotropin-releasing hormone analog in in vitro fertilization Fertil Steril 53 1990 854 858
17. C.T.B.J. Waegemaekers A. van de Berg A. Blankhart F.M. Helmerhorst N. Naaktgeboren Ovarian cyst formation during the use of a GnRH analogue in an IVF programme Acta Eur Fertil 18 1987 411
18. D. Fridberg J. Ashkenazi D. Dicker A. Yeshaya G.A. Goldman J.A. Goldman Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy Fertil Steril 51 1989 42 45
19. B.M. Sherman J.A. West S.G. Korenman The menopausal transition: analysis of LH, FSH, estradiol and progesterone concentrations during menstrual cycles of older women J Clin Endocrinol Metab 42 1976 629 636
20. M. Filicori P. Butler-James W.F. Crowley Jr. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion J Clin Invest 73 1984 1674 1680
21. J. Wilks A.S. Noble Steroidogenic responsiveness of the monkey corpus luteum to exogenous chorionic gonadotropin Endocrinology 1 3 1983 1256 1259
22. P. Serafini J. Batzofin J. Kerin R. Marrs Pregnancy: a risk to initiation of leuprolide acetate during the luteal phase before controlled ovarian hyperstimulation Fertil Steril 50 1988 371 372